Drug overdose deaths in the United States have fallen for the 18th consecutive month, the White House said on Monday, dropping 41.5 percent from the Biden-era peak to 65,724 deaths in the twelve months ending June 2026 — the lowest predicted provisional estimate since December 2016. The figures come from the Centers for Disease Control and Prevention’s most recent predicted provisional death estimates, highlighted by the White House Office of National Drug Control Policy, and they show deaths declining every month since President Trump took office in January 2025.
Why it matters: 65,724 deaths is still a national emergency by any measure — roughly 180 Americans a day — but the direction of the number is what changes life in households, schools and workplaces. At the peak, 112,418 Americans were dying in a twelve-month span; the difference, about 46,700 fewer deaths a year, is tens of thousands of families that did not get the call, tens of thousands of workers who stayed on the job, and a fentanyl crisis that for the first time in a decade is shrinking instead of growing.
The White House’s own words: “During this period, 65,724 overdose deaths are provisionally predicted to have occurred. Critically, this represents an approximately 41.5% decrease in total drug overdose deaths compared to the peak under the previous administration (112,418).” The release adds that the figure is “the lowest predicted provisional estimate of drug overdose deaths since December 2016” and that “drug overdose deaths have declined every month since President Trump took office in January 2025.”
The other side of the timeline belongs in the same breath. The decline did not start in January 2025. The CDC’s own series shows overdose deaths peaking in the summer of 2023 at 112,418 annualised deaths and falling substantially through 2024 — from about 110,000 deaths in 2023 to around 80,000 in 2024, a drop of roughly 27% — before Trump returned to office. A Johns Hopkins Bloomberg American Health Initiative analysis puts the same arc in numbers: from the August 2023 apex to an estimated 66,937 deaths in the twelve months ending April 2026, a decline of 40.5%, with the annualised death rate falling from 32.3 per 100,000 Americans in 2022–23 to 19.5 by April 2026. The White House is claiming the continuation of a decline that began under its predecessor, and the credit for the fall is shared across both administrations.
What the numbers do show, whichever administration claims them, is that the fall is broad and enduring. The Johns Hopkins paper calls the period from 2023 to 2026 “the only enduring decline in overdose deaths since the inception of the War on Drugs a half-century ago,” and notes that the biggest share of the decline has come in deaths involving synthetic opioids — overwhelmingly illicit fentanyl and its analogues — which accounted for the large majority of deaths at the peak. The CDC’s provisional counts also show the same pattern in the raw reported figures: a peak of 111,466 reported deaths in the twelve months ending June 2023, down to 70,646 in 2025 and 65,351 in the twelve months ending May 2026.
Two cautions belong with the headline figure. First, these are provisional predicted estimates, not final counts: the CDC warns they may be revised as more death records arrive, and the most recent months are flagged as underreported because the data are still incomplete. Second, the human scale has not changed as fast as the percentage: since the national peak in the summer of 2023, the same Johns Hopkins paper notes, an additional quarter of a million people have still died of an overdose, and more than 1.5 million Americans have died that way since 1979.
What happens next is the test of whether the decline holds. The White House presents the 18-month streak as the payoff of its drug policy — border enforcement that cut fentanyl seizures and a coordinated national strategy — while the researchers studying the fall point to a mix of causes: changes in the drug supply, in behaviour, and in interventions such as naloxone, whose distribution in community settings rose from 1.39 million units in 2018 to 16.1 million in 2023. If the streak reaches a second full year, the argument over who started it will matter less than the fact that the country is, for the first time in a generation, losing fewer of its people to drugs every single month.